Home/Filings/4/0001127602-22-017153
4//SEC Filing

ABERCROMBIE GEORGE B 4

Accession 0001127602-22-017153

CIK 0000882796other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:43 PM ET

Size

6.8 KB

Accession

0001127602-22-017153

Insider Transaction Report

Form 4
Period: 2022-06-07
Transactions
  • Award

    Common Stock

    2022-06-07+12,86612,866 total
  • Award

    Automatic Stock Option Grant

    2022-06-07+30,02230,022 total
    Exercise: $10.79From: 2023-06-07Exp: 2032-06-07Common Stock (30,022 underlying)
Footnotes (2)
  • [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
  • [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001485939

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:43 PM ET
Size
6.8 KB